Well, well, well…
“The conversations paint an in-depth picture of close, frequent contact about pricing and market decisions by way of LinkedIn, phone calls, text messages and emails — all with the goal of hiking prices on a broad range of generic drugs, the lawsuit claims.”
“Common drugs had their prices doubled, tripled, or even increased 1,000% or more, costing taxpayers and patients and violating federal and state competition and consumer protection laws, the suit alleges. There is also an ongoing U.S. Department of Justice criminal investigation.”
Warren is going to be busy.
